Literature DB >> 16648558

Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage.

Christopher M Sturgeon1, Zachary A Knight, Kevan M Shokat, Michel Roberge.   

Abstract

In response to DNA damage, cell survival can be enhanced by activation of DNA repair mechanisms and of checkpoints that delay cell cycle progression to allow more time for DNA repair. Inhibiting both responses with drugs might cause cancer cells to undergo cell division in the presence of lethal amounts of unrepaired DNA. However, we show that interfering with DNA repair via inhibition of DNA-dependent protein kinase (DNA-PK) reduces the ability of checkpoint inhibitors to abrogate G2 arrest and their radiosensitizing activity. Cells exposed to the DNA-PK inhibitor AMA37, DNA-PK-deficient cells, and nonhomologous end joining-deficient cells all enter prolonged G2 arrest after exposure to ionizing radiation doses as low as 2 Gy. The checkpoint kinase Chk2 becomes rapidly and transiently overactivated, whereas Chk1 shows sustained overactivation that parallels the prolonged accumulation of cells in G2. Therefore, in irradiated cells, DNA repair inhibition elicits abnormally strong checkpoint signaling that causes essentially irreversible G2 arrest and strongly reduces the ability of checkpoint kinase inhibitors to overcome G2 arrest and radiosensitize cells. Variable levels of proteins controlling DNA repair have been documented in cancer cells. Therefore, these results have relevance to the development of DNA-PK inhibitors and G2 checkpoint inhibitors as experimental therapeutic approaches to enhance the selective killing of tumor cells by radiotherapy or DNA-damaging chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648558     DOI: 10.1158/1535-7163.MCT-05-0358

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  15 in total

1.  PI3K-like kinases restrain Pim gene expression in endothelial cells.

Authors:  Xinwen Min; Jie Tang; Yinfang Wang; Minghua Yu; Libing Zhao; Handong Yang; Peng Zhang; Yexin Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 2.  E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA.

Authors:  Dragos Plesca; Meredith E Crosby; Damodar Gupta; Alexandru Almasan
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

3.  DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.

Authors:  Jarah A Meador; Yanrong Su; Jean-Luc Ravanat; Adayabalam S Balajee
Journal:  Carcinogenesis       Date:  2009-11-23       Impact factor: 4.944

4.  DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication.

Authors:  Tsutomu Shimura; Melvenia M Martin; Michael J Torres; Cory Gu; Janice M Pluth; Maria A DeBernardi; Maria A DiBernardi; Jeffrey S McDonald; Mirit I Aladjem
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

5.  DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.

Authors:  Sonnet J H Arlander; Bryan T Greene; Cynthia L Innes; Richard S Paules
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

6.  Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells.

Authors:  Yi Chieh Lim; Tara L Roberts; Bryan W Day; Brett W Stringer; Sergei Kozlov; Shazrul Fazry; Zara C Bruce; Kathleen S Ensbey; David G Walker; Andrew W Boyd; Martin F Lavin
Journal:  Mol Oncol       Date:  2014-06-27       Impact factor: 6.603

7.  Suppression of nonhomologous end joining repair by overexpression of HMGA2.

Authors:  Angela Y J Li; Lee Ming Boo; Shih-Ya Wang; H Helen Lin; Clay C C Wang; Yun Yen; Benjamin P C Chen; David J Chen; David K Ann
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

8.  Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.

Authors:  Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Timothy S Pardee; David L Caudell
Journal:  Leuk Res       Date:  2012-11-04       Impact factor: 3.156

9.  TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements.

Authors:  Liqin Zheng; Nicole Asprodites; Angela H Keene; Paulo Rodriguez; Kevin D Brown; Eduardo Davila
Journal:  Blood       Date:  2007-12-17       Impact factor: 22.113

Review 10.  New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.

Authors:  Melissa S Bentle; Erik A Bey; Ying Dong; Kathryn E Reinicke; David A Boothman
Journal:  J Mol Histol       Date:  2006-07-26       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.